The fate of HIV-1 capsid: A biochemical assay for HIV-1 uncoating

Methods in Molecular Biology

Volumn 1087, Issue , 2014, Pages 29-36

  Yang, Yang ^a   Luban, Jeremy ^b   Diaz Griffero, Felipe ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Capsid; HIV 1 core; Sucrose cushion; TRIM5 ; Uncoating

Indexed keywords

CAPSID PROTEIN;

ANALYTIC METHOD; ARTICLE; BIOCHEMISTRY; HELA CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROMOTER REGION; TARGET CELL; VIRUS CAPSID;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

ANIMALS; CAPSID; CAPSID PROTEINS; HELA CELLS; HIV-1; HUMANS; PROTEIN SUBUNITS; VIRUS REPLICATION;

EID: 84934437891     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-670-2_3     Document Type: Article

References (31)

1. Suzuki Y, Craigie R (2007) The road to chromatin-nuclear entry of retroviruses. Nat Rev Microbiol 5:187-196
2. Iordanskiy S, Berro R, Altieri M, Kashanchi F, Bukrinsky M (2006) Intracytoplasmic maturation of the human immunodefi ciency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin. Retrovirology 3:4
3. Miller MD, Farnet CM, Bushman FD (1997) Human immunodefi ciency virus type 1 preintegration complexes: studies of organization and composition. J Virol 71:5382-5390
4. Fassati A, Goff SP (2001) Characterization of intracellular reverse transcription complexes of human immunodefi ciency virus type 1. J Virol 75:3626-3635
5. Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG, Stevenson M (1993) Association of integrase, matrix, and reverse transcriptase antigens of human immunodefi ciency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci USA 90:6125-6129
6. Roa A, Hayashi F, Yang Y, Lienlaf M, Zhou J, Shi J, Watanabe S, Kigawa T, Yokoyama S, Aiken C, Diaz-Griffero F (2011) RING domain mutations uncouple TRIM5alpha restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating. J Virol 86(3):1717-1727
7. Hulme AE, Perez O, Hope TJ (2011) Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription. Proc Natl Acad Sci USA 108:9975-9980
8. Diaz-Griffero F, Kar A, Lee M, Stremlau M, Poeschla E, Sodroski J (2007) Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp. Virology 369(2):400-410
9. Perron MJ, Stremlau M, Lee M, Javanbakht H, Song B, Sodroski J (2007) The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid. J Virol 81:2138-2148
10. Diaz-Griffero F, Perron M, McGee-Estrada K, Hanna R, Maillard PV, Trono D, Sodroski J (2008) A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus. Virology 378:233-242
11. Ohkura S, Goldstone DC, Yap MW, Holden-Dye K, Taylor IA, Stoye JP (2011) Novel escape mutants suggest an extensive TRIM5alpha binding site spanning the entire outer surface of the murine leukemia virus capsid protein. PLoS Pathog 7:e1002011
12. Stremlau M, Perron M, Lee M, Li Y, Song B, Javanbakht H, Diaz-Griffero F, Anderson DJ, Sundquist WI, Sodroski J (2006) Specifi c recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci USA 103:5514-5519
13. Diaz-Griffero F, Kar A, Perron M, Xiang SH, Javanbakht H, Li X, Sodroski J (2007) Modulation of retroviral restriction and proteasome inhibitor-resistant turnover by changes in the TRIM5alpha B-box 2 domain. J Virol 81:10362-10378
14. Shi J, Zhou J, Shah VB, Aiken C, Whitby K (2011) Small-molecule inhibition of human immunodefi ciency virus type 1 infection by virus capsid destabilization. J Virol 85: 542-549
15. Berube J, Bouchard A, Berthoux L (2007) Both TRIM5alpha and TRIMCyp have only weak antiviral activity in canine D17 cells. Retrovirology 4:68
16. Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, Stout CD, Sundquist WI, Hill CP, Yeager M (2009) X-ray structures of the hexameric building block of the HIV capsid. Cell 137:1282-1292
17. Ganser-Pornillos BK, Yeager M, Sundquist WI (2008) The structural biology of HIV assembly. Curr Opin Struct Biol 18:203-217
18. Briggs JA, Simon MN, Gross I, Krausslich HG, Fuller SD, Vogt VM, Johnson MC (2004) The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol 11:672-675
19. Briggs JA, Wilk T, Welker R, Krausslich HG, Fuller SD (2003) Structural organization of authentic, mature HIV-1 virions and cores. EMBO J 22:1707-1715
20. McDonald D, Vodicka MA, Lucero G, Svitkina TM, Borisy GG, Emerman M, Hope TJ (2002) Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 159: 441-452
21. Forshey BM, von Schwedler U, Sundquist WI, Aiken C (2002) Formation of a human immunodefi ciency virus type 1 core of optimal stability is crucial for viral replication. J Virol 76:5667-5677
22. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J (2004) The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-853
23. Asmal M, Colgan J, Naef F, Yu B, Lee Y, Magnasco M, Luban J (2003) Production of ribosome components in effector CD4+ T cells is accelerated by TCR stimulation and coordinated by ERK-MAPK. Immunity 19: 535-548
24. Sayah DM, Sokolskaja E, Berthoux L, Luban J (2004) Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430:569-573
25. Neagu MR, Ziegler P, Pertel T, Strambio-De-Castillia C, Grutter C, Martinetti G, Mazzucchelli L, Grutter M, Manz MG, Luban J (2009) Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. J Clin Invest 119: 3035-3047
26. Pertel T, Hausmann S, Morger D, Zuger S, Guerra J, Lascano J, Reinhard C, Santoni FA, Uchil PD, Chatel L, Bisiaux A, Albert ML, Strambio-De-Castillia C, Mothes W, Pizzato M, Grutter MG, Luban J (2011) TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472:361-365
27. Sayah DM, Luban J (2004) Selection for loss of Ref1 activity in human cells releases human immunodefi ciency virus type 1 from cyclophilin A dependence during infection. J Virol 78:12066-12070
28. Berthoux L, Sebastian S, Sayah DM, Luban J (2005) Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues. J Virol 79:7883-7888
29. McEwan WA, Schaller T, Ylinen LM, Hosie MJ, Towers GJ, Willett BJ (2009) Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat. J Virol 83:8270-8275
30. O'Doherty U, Swiggard WJ, Malim MH (2000) Human immunodefi ciency virus type 1 spinoculation enhances infection through virus binding. J Virol 74:10074-10080
31. Pauza CD, Price TM (1988) Human immunodefi ciency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis. J Cell Biol 107:959-968